Abstract
Background: The Experimental Tobacco Marketplace (ETM) is a digital storefront in which participants can purchase tobacco products using an account balance that reflects their typical tobacco product purchasing. The ETM is also an ideal resource to investigate the harm-reduction potential of alternative nicotine products such as e-cigarettes. In a series of experiments, we explored the effects of harm-reduction narratives that encouraged e-cigarette substitution of conventional cigarettes in the ETM. These narratives incorporated different cognitive biases in order to determine which strategy is most effective. Methods: In both experiments, participants, recruited from Amazon Mechanical Turk, read a narrative about a friend that either falls ill or faces financial difficulties and then made purchases in the ETM. Some of these narratives specifically incorporated different cognitive biases including trusting authority. Across ETM trials, the price of conventional cigarettes increased while the price of the alternative products, including e-cigarettes, remained constant. Results: Across both experiments, a general pattern emerged supporting the effectiveness of narratives in increasing e-cigarette purchasing. Importantly, from a harm-reduction perspective, this increase in e-cigarette substitution frequently corresponded with a decrease in conventional cigarette purchasing. Conclusions: Narratives can decrease conventional cigarette and increase e-cigarette purchasing in an ETM that mimics real-world marketplaces. Invoking different cognitive biases may bolster this effect. Narratives can be a valuable harm-reduction tool because they are cost-effective, can be widely disseminated, and can be personalized to individuals.
Original language | English |
---|---|
Pages (from-to) | 203-211 |
Number of pages | 9 |
Journal | Drug and Alcohol Dependence |
Volume | 197 |
DOIs | |
State | Published - Apr 1 2019 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier B.V.
Funding
This work was supported by the Fralin Biomedical Research Institute at VTC and by NIH Grant No. R01DA034755 . This work was also supported by NIDA/NIH grant R01DA042535 and FDA Center for Tobacco Products (CTP) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. This work was supported by the Fralin Biomedical Research Institute at VTC and by NIH Grant No. R01DA034755. This work was also supported by NIDA/NIH grant R01DA042535 and FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.
Funders | Funder number |
---|---|
Fralin Biomedical Research Institute | |
NIH/NIDA | |
National Institutes of Health (NIH) | |
National Institute on Drug Abuse | R01DA034755, R01DA042535 |
U.S. Food and Drug Administration | |
Center for Tobacco Products (CTP) | |
Norges Idrettshøgskole |
Keywords
- Behavioral economics
- Demand
- Experimental tobacco marketplace
- Harm-reduction
- Narratives
ASJC Scopus subject areas
- Toxicology
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)